{"result": "(\"entity\"<|>DIURÉTICOS<|>EVENT<|>Diuréticos are medications used to promote diuresis, which can be relevant in the treatment of various medical conditions, including adrenal insufficiency.)\n##\n(\"entity\"<|>GENOTIPO<|>PERSON<|>Genotipo refers to the genetic constitution of an individual, which can influence the expression of certain traits and conditions, including adrenal disorders.)\n##\n(\"entity\"<|>FENOTIPO<|>PERSON<|>Fenotipo refers to the observable characteristics of an individual, which can be affected by genetic and environmental factors, including those related to adrenal function.)\n##\n(\"entity\"<|>MÉXICO DF<|>GEO<|>México DF is the capital city of Mexico, where medical literature and guidelines may be published and referenced.)\n##\n(\"entity\"<|>KASPER DL<|>PERSON<|>Kasper DL is an editor of the Harrison Principios de Medicina Interna, contributing to the field of internal medicine.)\n##\n(\"entity\"<|>HAUSER SL<|>PERSON<|>Hauser SL is an editor of the Harrison Principios de Medicina Interna, known for his work in internal medicine.)\n##\n(\"entity\"<|>JAMESON JL<|>PERSON<|>Jameson JL is an editor of the Harrison Principios de Medicina Interna, recognized for his contributions to medical education.)\n##\n(\"entity\"<|>FAUCI AS<|>PERSON<|>Fauci AS is an editor of the Harrison Principios de Medicina Interna, noted for his expertise in infectious diseases and public health.)\n##\n(\"entity\"<|>LONGO DL<|>PERSON<|>Longo DL is an editor of the Harrison Principios de Medicina Interna, known for his work in internal medicine.)\n##\n(\"entity\"<|>LOSCAZO J<|>PERSON<|>Loscazo J is an editor of the Harrison Principios de Medicina Interna, contributing to the field of internal medicine.)\n##\n(\"entity\"<|>ARLT W<|>PERSON<|>Arlt W is a contributor to the literature on adrenal disorders, specifically in the context of congenital adrenal hyperplasia.)\n##\n(\"entity\"<|>AUCHUS RJ<|>PERSON<|>Auchus RJ is a medical expert who has published guidelines on the treatment of congenital adrenal hyperplasia.)\n##\n(\"entity\"<|>SPEISER PW<|>PERSON<|>Speiser PW is a contributor to the guidelines on congenital adrenal hyperplasia, providing insights into its management.)\n##\n(\"entity\"<|>BASKIN LS<|>PERSON<|>Baskin LS is a medical professional involved in the research and treatment of adrenal disorders.)\n##\n(\"entity\"<|>CONWAY GS<|>PERSON<|>Conway GS is a medical expert who has contributed to the understanding of adrenal disorders, including congenital adrenal hyperplasia.)\n##\n(\"entity\"<|>MERKE DP<|>PERSON<|>Merke DP is a researcher and clinician focused on congenital adrenal hyperplasia and its treatment.)\n##\n(\"relationship\"<|>GENOTIPO<|>FENOTIPO<|>Genotype and phenotype are related concepts in genetics, where genotype influences the phenotype expressed in individuals.<|>6)\n##\n(\"relationship\"<|>KASPER DL<|>HARRISON PRINCIPIOS DE MEDICINA INTERNA<|>Kasper DL is one of the editors of the Harrison Principios de Medicina Interna, contributing to its content and authority.<|>8)\n##\n(\"relationship\"<|>HAUSER SL<|>HARRISON PRINCIPIOS DE MEDICINA INTERNA<|>Hauser SL is one of the editors of the Harrison Principios de Medicina Interna, contributing to its content and authority.<|>8)\n##\n(\"relationship\"<|>JAMESON JL<|>HARRISON PRINCIPIOS DE MEDICINA INTERNA<|>Jameson JL is one of the editors of the Harrison Principios de Medicina Interna, contributing to its content and authority.<|>8)\n##\n(\"relationship\"<|>FAUCI AS<|>HARRISON PRINCIPIOS DE MEDICINA INTERNA<|>Fauci AS is one of the editors of the Harrison Principios de Medicina Interna, contributing to its content and authority.<|>8)\n##\n(\"relationship\"<|>LONGO DL<|>HARRISON PRINCIPIOS DE MEDICINA INTERNA<|>Longo DL is one of the editors of the Harrison Principios de Medicina Interna, contributing to its content and authority.<|>8)\n##\n(\"relationship\"<|>LOSCAZO J<|>HARRISON PRINCIPIOS DE MEDICINA INTERNA<|>Loscazo J is one of the editors of the Harrison Principios de Medicina Interna, contributing to its content and authority.<|>8)\n##\n(\"relationship\"<|>ARLT W<|>HARRISON PRINCIPIOS DE MEDICINA INTERNA<|>Arlt W has contributed to the literature on adrenal disorders, which is referenced in the Harrison Principios de Medicina Interna.<|>7)\n##\n(\"relationship\"<|>AUCHUS RJ<|>UPTODATE<|>Auchus RJ provides treatment guidelines for congenital adrenal hyperplasia, which are available on UpToDate.<|>7)\n##\n(\"relationship\"<|>SPEISER PW<|>J CLIN ENDOCRINOL METAB<|>Speiser PW has published research on congenital adrenal hyperplasia in J Clin Endocrinol Metab.<|>7)\n##\n(\"relationship\"<|>BASKIN LS<|>WILLIAMS TEXTBOOK OF ENDOCRINOLOGY<|>Baskin LS has contributed to the Williams Textbook of Endocrinology, which covers adrenal disorders.<|>7)\n##\n(\"relationship\"<|>CONWAY GS<|>WILLIAMS TEXTBOOK OF ENDOCRINOLOGY<|>Conway GS has contributed to the Williams Textbook of Endocrinology, which covers adrenal disorders.<|>7)\n##\n(\"relationship\"<|>MERKE DP<|>WILLIAMS TEXTBOOK OF ENDOCRINOLOGY<|>Merke DP has contributed to the Williams Textbook of Endocrinology, which covers adrenal disorders.<|>7)\n<|COMPLETE|>", "input": "MANY entities and relationships were missed in the last extraction. Remember to ONLY emit entities that match any of the previously extracted types. Add them below using the same format:\n", "parameters": {"model": "gpt-4o-mini", "temperature": 0.0, "frequency_penalty": 0.0, "presence_penalty": 0.0, "top_p": 1.0, "max_tokens": 4000, "n": 1}, "history": [{"role": "user", "content": "\n-Goal-\nGiven a text document that is potentially relevant to this activity and a list of entity types, identify all entities of those types from the text and all relationships among the identified entities.\n \n-Steps-\n1. Identify all entities. For each identified entity, extract the following information:\n- entity_name: Name of the entity, capitalized\n- entity_type: One of the following types: [organization,person,geo,event]\n- entity_description: Comprehensive description of the entity's attributes and activities\nFormat each entity as (\"entity\"<|><entity_name><|><entity_type><|><entity_description>)\n \n2. From the entities identified in step 1, identify all pairs of (source_entity, target_entity) that are *clearly related* to each other.\nFor each pair of related entities, extract the following information:\n- source_entity: name of the source entity, as identified in step 1\n- target_entity: name of the target entity, as identified in step 1\n- relationship_description: explanation as to why you think the source entity and the target entity are related to each other\n- relationship_strength: a numeric score indicating strength of the relationship between the source entity and target entity\n Format each relationship as (\"relationship\"<|><source_entity><|><target_entity><|><relationship_description><|><relationship_strength>)\n \n3. Return output in English as a single list of all the entities and relationships identified in steps 1 and 2. Use **##** as the list delimiter.\n \n4. When finished, output <|COMPLETE|>\n \n######################\n-Examples-\n######################\nExample 1:\nEntity_types: ORGANIZATION,PERSON\nText:\nThe Verdantis's Central Institution is scheduled to meet on Monday and Thursday, with the institution planning to release its latest policy decision on Thursday at 1:30 p.m. PDT, followed by a press conference where Central Institution Chair Martin Smith will take questions. Investors expect the Market Strategy Committee to hold its benchmark interest rate steady in a range of 3.5%-3.75%.\n######################\nOutput:\n(\"entity\"<|>CENTRAL INSTITUTION<|>ORGANIZATION<|>The Central Institution is the Federal Reserve of Verdantis, which is setting interest rates on Monday and Thursday)\n##\n(\"entity\"<|>MARTIN SMITH<|>PERSON<|>Martin Smith is the chair of the Central Institution)\n##\n(\"entity\"<|>MARKET STRATEGY COMMITTEE<|>ORGANIZATION<|>The Central Institution committee makes key decisions about interest rates and the growth of Verdantis's money supply)\n##\n(\"relationship\"<|>MARTIN SMITH<|>CENTRAL INSTITUTION<|>Martin Smith is the Chair of the Central Institution and will answer questions at a press conference<|>9)\n<|COMPLETE|>\n\n######################\nExample 2:\nEntity_types: ORGANIZATION\nText:\nTechGlobal's (TG) stock skyrocketed in its opening day on the Global Exchange Thursday. But IPO experts warn that the semiconductor corporation's debut on the public markets isn't indicative of how other newly listed companies may perform.\n\nTechGlobal, a formerly public company, was taken private by Vision Holdings in 2014. The well-established chip designer says it powers 85% of premium smartphones.\n######################\nOutput:\n(\"entity\"<|>TECHGLOBAL<|>ORGANIZATION<|>TechGlobal is a stock now listed on the Global Exchange which powers 85% of premium smartphones)\n##\n(\"entity\"<|>VISION HOLDINGS<|>ORGANIZATION<|>Vision Holdings is a firm that previously owned TechGlobal)\n##\n(\"relationship\"<|>TECHGLOBAL<|>VISION HOLDINGS<|>Vision Holdings formerly owned TechGlobal from 2014 until present<|>5)\n<|COMPLETE|>\n\n######################\nExample 3:\nEntity_types: ORGANIZATION,GEO,PERSON\nText:\nFive Aurelians jailed for 8 years in Firuzabad and widely regarded as hostages are on their way home to Aurelia.\n\nThe swap orchestrated by Quintara was finalized when $8bn of Firuzi funds were transferred to financial institutions in Krohaara, the capital of Quintara.\n\nThe exchange initiated in Firuzabad's capital, Tiruzia, led to the four men and one woman, who are also Firuzi nationals, boarding a chartered flight to Krohaara.\n\nThey were welcomed by senior Aurelian officials and are now on their way to Aurelia's capital, Cashion.\n\nThe Aurelians include 39-year-old businessman Samuel Namara, who has been held in Tiruzia's Alhamia Prison, as well as journalist Durke Bataglani, 59, and environmentalist Meggie Tazbah, 53, who also holds Bratinas nationality.\n######################\nOutput:\n(\"entity\"<|>FIRUZABAD<|>GEO<|>Firuzabad held Aurelians as hostages)\n##\n(\"entity\"<|>AURELIA<|>GEO<|>Country seeking to release hostages)\n##\n(\"entity\"<|>QUINTARA<|>GEO<|>Country that negotiated a swap of money in exchange for hostages)\n##\n##\n(\"entity\"<|>TIRUZIA<|>GEO<|>Capital of Firuzabad where the Aurelians were being held)\n##\n(\"entity\"<|>KROHAARA<|>GEO<|>Capital city in Quintara)\n##\n(\"entity\"<|>CASHION<|>GEO<|>Capital city in Aurelia)\n##\n(\"entity\"<|>SAMUEL NAMARA<|>PERSON<|>Aurelian who spent time in Tiruzia's Alhamia Prison)\n##\n(\"entity\"<|>ALHAMIA PRISON<|>GEO<|>Prison in Tiruzia)\n##\n(\"entity\"<|>DURKE BATAGLANI<|>PERSON<|>Aurelian journalist who was held hostage)\n##\n(\"entity\"<|>MEGGIE TAZBAH<|>PERSON<|>Bratinas national and environmentalist who was held hostage)\n##\n(\"relationship\"<|>FIRUZABAD<|>AURELIA<|>Firuzabad negotiated a hostage exchange with Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>AURELIA<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>FIRUZABAD<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>ALHAMIA PRISON<|>Samuel Namara was a prisoner at Alhamia prison<|>8)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>MEGGIE TAZBAH<|>Samuel Namara and Meggie Tazbah were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>DURKE BATAGLANI<|>Samuel Namara and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>DURKE BATAGLANI<|>Meggie Tazbah and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>FIRUZABAD<|>Samuel Namara was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>FIRUZABAD<|>Meggie Tazbah was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>DURKE BATAGLANI<|>FIRUZABAD<|>Durke Bataglani was a hostage in Firuzabad<|>2)\n<|COMPLETE|>\n\n######################\n-Real Data-\n######################\nEntity_types: organization,person,geo,event\nText: les por tratamiento previo con diuréticos.\n               se han observado divergencias entre genotipo y fenotipo que podrían depender de otros\n               genes que interaccionan con CYP21A2 y del proceso de maduración.                                                                          C. Ninguna de las anteriores.\n               Las mutaciones de novo en el trascurso de la gametogénesis o en el desarrollo fetal son                                                   D.  A y B son ciertas.\n               excepcionales.                                                                                                                            En el paciente presentado, lo que se describe a continuación puede ser cierto\n                                                                                                                                                     49\n               Referencias:                                                                                                                              o correcto, excepto:\n               • Arlt W. Trastornos de la corteza suprarrenal. En: Kasper DL, Hauser SL, Jameson JL, Fauci AS, Longo DL, Loscazo J, eds. Harrison\n                 Principios de Medicina Interna. 19.ª edición en español. México DF: Mc Graw Hill; 2016. p. 2309-29.                                     A. Los resultados analíticos obtenidos en la UVI móvil se debieron probablemente a una\n               • Auchus RJ. Treatment of classic congenital adrenal hyperplasia due to 21-hydroxilasa deficiency in adults. UpToDate. Waltham,\n                 MA: UpToDate Inc. https://www.uptodate.com. Literature review current through: Apr. 2019.                                                   venopunción muy próxima al lugar de infusión del suero fisiológico.\n               • Rodríguez Arnao MD, Sanz Fernández M, Rodríguez Sánchez A. Hiperplasia adrenal congénita. Manual de Endocrinología y Nutrición.         B. El tratamiento con potasio i.v. puede ser arritmogénico o incluso letal.\n                 Disponible en: https://manual.seen.es (última modificación: 25 de noviembrede 2015).\n               • Speiser PW, Arlt W, Auchus RJ, Baskin LS, Conway GS, Merke DP, et al. Congenital adrenal hyperplasia due to steroid 21-hydroxilasa      C. Un glucocorticoide potente (tipo metilprednisolona) era de elección en las primeras\n                 deficiency: an Endocrine Society Practice Guideline.\n                 J Clin Endocrinol Metab. 2018;103:4043-88.                                                                                                  24 horas de tratamiento de la crisis.\n               • Steward PM, Newell-Price JDC. The adrenal cortex. En: Melmed S, Polonsky KS, Larsen PR, Kronenberg HM, eds. Williams Textbook\n                 of Endocrinology. 13.ª ed. Philadelphia: Elsevier; 2016. p. 490-555.                                                                    D.  Si se dio por cierta la hipoglucemia, debió utilizarse una reposición de fluidos que\n                                                                                                                                                             combinase suero fisológico con suero glucosado.\n\n\n\n     5.8 Casos clínicos. Caso clínico 1                                                                                                                  COMENTARIO\n                                                                                                                                                         La insuficiencia suprarrenal aguda o crisis suprarrenal es una emergencia médica que se\n        46     Son síntomas o signos compatibles con la insuficiencia suprarrenal aguda (aunque                                                          manifiesta como hipotensión asociada a depleción de volumen. La anorexia puede ser una\n               no estén forzosamente presentes en todos los pacientes) los siguientes, excepto:                                                          característica temprana que progresa a náuseas, vómitos, diarrea y, en ocasiones, dolor\n                                                                                                                                                         abdominal. La fiebre puede estar presente y también puede haber tendencia a la hipoglu-\n               A. Hipotensión sensible a fármacos vasopresores.                                                                                          cemia (más marcada si se trata de una insuficiencia suprarrenal central por la coexistencia\n               B. Deshidratación.                                                                                                                        posible del déficit de GH).\n               C. Náuseas, vómitos, dolor abdominal.                                                                                                     En la insuficiencia suprarrenal primaria establecida, la hiponatremia se halla presente en\n               D.  Fiebre.                                                                                                                               aproximadamente el 90% de los pacientes, y la hiperpotasemia en el 65% de los casos. La\n                                                                                                                                                         concentración de urea suele estar elevada como manifestación de insuficiencia renal de\n        47     Son hallazgos analíticos compatibles con la insuficiencia suprarrenal aguda                                                               origen prerrenal. En el 6% de todos los casos se produce hipercalcemia, y puede ser parti-\n               (aunque no estén forzosamente presentes en todos los pacientes) los siguientes,                                                           cularmente acusada en los pacientes con tirotoxicosis coexistente. El 17% de los pacientes\n               excepto:                                                                                                                                  presentan eosinofilia.\n               A. Fracaso renal agudo.                                                                                                                   La insuficiencia suprarrenal aguda es una emergencia médica que pone en riesgo la vida\n               B. Hipocalcemia.                                                                                                                          del paciente, y su tratamiento no debe demorarse por esperar a la realización de pruebas\n                                                                                                                                                         diagnósticas definitivas.          No ob\n######################\nOutput:"}, {"role": "assistant", "content": "(\"entity\"<|>HARRISON PRINCIPIOS DE MEDICINA INTERNA<|>ORGANIZATION<|>Harrison Principios de Medicina Interna is a medical textbook that provides comprehensive information on various medical conditions and treatments, including adrenal disorders.)\n##\n(\"entity\"<|>UPTODATE<|>ORGANIZATION<|>UpToDate is a clinical decision support resource that provides evidence-based information for healthcare professionals, including treatment guidelines for congenital adrenal hyperplasia.)\n##\n(\"entity\"<|>MANUAL DE ENDOCRINOLOGÍA Y NUTRICIÓN<|>ORGANIZATION<|>Manual de Endocrinología y Nutrición is a reference manual that covers various endocrine disorders, including congenital adrenal hyperplasia.)\n##\n(\"entity\"<|>J CLIN ENDOCRINOL METAB<|>ORGANIZATION<|>J Clin Endocrinol Metab is a scientific journal that publishes research and guidelines related to endocrinology, including adrenal disorders.)\n##\n(\"entity\"<|>WILLIAMS TEXTBOOK OF ENDOCRINOLOGY<|>ORGANIZATION<|>Williams Textbook of Endocrinology is a comprehensive textbook that covers various aspects of endocrinology, including adrenal gland disorders.)\n##\n(\"entity\"<|>INSUFICIENCIA SUPRARRENAL AGUDA<|>EVENT<|>Insuficiencia suprarrenal aguda is a medical emergency characterized by acute adrenal insufficiency, leading to symptoms such as hypotension, dehydration, and electrolyte imbalances.)\n##\n(\"entity\"<|>CYP21A2<|>PERSON<|>CYP21A2 is a gene that plays a crucial role in steroidogenesis and is associated with congenital adrenal hyperplasia.)\n##\n(\"entity\"<|>PACIENTE<|>PERSON<|>The patient presented in the clinical case is experiencing symptoms related to acute adrenal insufficiency.)\n##\n(\"relationship\"<|>HARRISON PRINCIPIOS DE MEDICINA INTERNA<|>UPTODATE<|>Both resources provide information on the treatment and management of adrenal disorders, including congenital adrenal hyperplasia.<|>7)\n##\n(\"relationship\"<|>HARRISON PRINCIPIOS DE MEDICINA INTERNA<|>MANUAL DE ENDOCRINOLOGÍA Y NUTRICIÓN<|>Both texts discuss adrenal disorders and provide clinical guidelines for their management.<|>7)\n##\n(\"relationship\"<|>UPTODATE<|>MANUAL DE ENDOCRINOLOGÍA Y NUTRICIÓN<|>Both resources offer evidence-based information on the treatment of congenital adrenal hyperplasia.<|>7)\n##\n(\"relationship\"<|>J CLIN ENDOCRINOL METAB<|>WILLIAMS TEXTBOOK OF ENDOCRINOLOGY<|>Both publications contribute to the understanding and management of endocrine disorders, including adrenal insufficiency.<|>7)\n##\n(\"relationship\"<|>INSUFICIENCIA SUPRARRENAL AGUDA<|>PACIENTE<|>The patient is experiencing acute adrenal insufficiency, which is a medical emergency requiring immediate treatment.<|>9)\n##\n(\"relationship\"<|>CYP21A2<|>INSUFICIENCIA SUPRARRENAL AGUDA<|>Mutations in the CYP21A2 gene are associated with congenital adrenal hyperplasia, which can lead to acute adrenal insufficiency.<|>8)\n<|COMPLETE|>"}]}